Artículos del autor

solaci

Thin vs. Ultrathin Stents: 1-Year Clinical Results After IVUS/OCT-Guided Implantation

Second generation drug-eluting stents have lower frequency of thrombotic complications and in-stent restenosis. While clinical results have...

Angioplasty in Nonagenarians Is Increasingly Frequent: How Does It Evolve?

Currently, the number of nonagenarian patients undergoing angioplasty (whether elective, urgent or emergency) has increased.  This population is...

‘+25 International Guests Will Be Sharing their Knowledge at SOLACI-SOCIME 2022

+25 INTERNATIONAL GUESTS WILL BE SHARING THEIR KNOWLEDGE AT SOLACI-SOCIME 2022 Why is SOLACI-SOCIME 2022 an unmissable event...

Register to the SOLACI-SOCIME 2022 Virtual Sessions

REGISTER TO THE CONGRESS VIRTUAL SESSIONS This year, SOLACI-SOCIME 2022 will stream live all scientific sessions at the Main Arena from...

TRICVALVE in Patients with Severe Tricuspid Regurgitation: Promising Results at 6 months

Severe tricuspid regurgitation (TR) is associated with high mortality and morbidity. For patients with high surgical risk...

Antithrombotic Therapy Post Percutaneous Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAO) with Watchman has FDA approval since March 2015, having shown, in...

Three-Year Outcomes after CTA with 2-Stent Technique Vs. Provisional Stenting for Complex Bifurcation Lesions

The prevalence of coronary lesions with bifurcation involvement is about 20% in patients undergoing coronary angiography (CTA)....

Watch again Disruptive and Conventional Treatments Below The Knee and in the Superficial Femoral Artery – SOLACI Webinar

Watch again Disruptive and Conventional Treatments Below The Knee and in the Superficial Femoral Artery on our Youtube...